Indian indapamide market is estimated to grow at a CAGR of around 4.0% during the forecast period owing to the significant prevalence of chronic diseases in the region. According to the Cardiological Society of India, the Trivandrum heart failure registry had registered 1,205 admissions due to heart failure in 2018, of which 834 in men, indicating around 69% of total heart failures in Trivandrum. In addition, the most common cause of heart failure includes ischemic heart disease, which is accounted for 72% of heart failures in India in 2018. Heart failure with preserved ejection fraction (HFpEF) accounted for 26%. This, in turn, is expected to drive the demand for indapamide tablets that enable to treat fluid retention (edema) in patients suffering from congestive heart failure.

Request a free sample of our report on Indian Indapamide Market: https://www.omrglobal.com/request-sample/indian-indapamide-market



Indian indapamide market is segmented on the basis of product and application. Based on the product, the market is bifurcated into 1.25 mg indapamide and 2.5 mg indapamide. Among these, the market for 1.25 mg indapamide held a significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have a significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.

A full report of Indian Indapamide Market Is available at Global Anti-Acne https://www.omrglobal.com/industry-reports/indian-indapamide-market

Indian Indapamide Market Segmentation

By Product

1.25 MG

2.5 MG

By Application

High Blood Pressure

Heart Failure

Others

Company Profiles

ANI Pharmaceuticals, Inc.

Glenmark Pharmaceuticals Ltd.

Merck KGaA

Sandoz International GmbH

Sanofi S.A.

Shandong Yinfeida Pharmaceutical Co., Ltd.

Supra Chemicals

Suzhou Lixin Pharmaceutical Co., Ltd.

Taj Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/indian-indapamide-market

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.



For More Information, Visit https://www.omrglobal.com/



Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404